About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

First patient enrolled in Pharming APSD trial  

Biocytogen launches nanobody therapeutics project for 100 targets

FDA approves alpha-mannosidosis drug

Interview 17 Feb 2023

The benefits – and challenges – of in-house CAR T-cell therapy

Positive results for INOVIO recurrent respiratory papillomatosis trial

Immuno Cure starts HIV drug trial

ADVERTISEMENT

Avilar Therapeutics financing up to $75M to boost extracellular protein degraders pipeline

Beyond Biotech podcast 34: eClinical Solutions, GPCR Therapeutics, Orbsen Therapeutics

Newron reports ‘striking’ schizophrenia study results 

Maxion Therapeutics raises $16M to target GPCRs

Bladder cancer investigational therapy may be given at home

ADVERTISEMENT